Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24


Relationships Between Material Hardship, Resilience, and Health Care Use.

Fuller AE, Garg A, Brown NM, Tripodis Y, Oyeku SO, Gross RS.

Pediatrics. 2020 Feb;145(2). pii: e20191975. doi: 10.1542/peds.2019-1975. Epub 2020 Jan 16.


Material Hardships and Health Care Utilization Among Low-Income Children with Special Health Care Needs.

Fuller AE, Brown NM, Grado L, Oyeku SO, Gross RS.

Acad Pediatr. 2019 Sep - Oct;19(7):733-739. doi: 10.1016/j.acap.2019.01.009. Epub 2019 Mar 8.


Corrigendum to "Hepatic Iron Quantification on 3 Tesla (3 T) Magnetic Resonance (MR): Technical Challenges and Solutions".

Anwar M, Wood J, Manwani D, Taragin B, Oyeku SO, Peng Q.

Radiol Res Pract. 2018 Jun 3;2018:8142478. doi: 10.1155/2018/8142478. eCollection 2018.


Prenatal Material Hardships and Infant Regulatory Capacity at 10 Months Old in Low-Income Hispanic Mother-Infant Pairs.

Fuller A, Messito MJ, Mendelsohn AL, Oyeku SO, Gross RS.

Acad Pediatr. 2018 Nov - Dec;18(8):897-904. doi: 10.1016/j.acap.2018.04.134. Epub 2018 May 2.


Rigorous and practical quality indicators in sickle cell disease care.

Oyeku SO, Faro EZ.

Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):418-422. doi: 10.1182/asheducation-2017.1.418. Review.


Association of Guideline-Adherent Antibiotic Treatment With Readmission of Children With Sickle Cell Disease Hospitalized With Acute Chest Syndrome.

Bundy DG, Richardson TE, Hall M, Raphael JL, Brousseau DC, Arnold SD, Kalpatthi RV, Ellison AM, Oyeku SO, Shah SS.

JAMA Pediatr. 2017 Nov 1;171(11):1090-1099. doi: 10.1001/jamapediatrics.2017.2526.


Associations Between Adverse Childhood Experiences and ADHD Diagnosis and Severity.

Brown NM, Brown SN, Briggs RD, Germán M, Belamarich PF, Oyeku SO.

Acad Pediatr. 2017 May - Jun;17(4):349-355. doi: 10.1016/j.acap.2016.08.013.


Quality Indicator Development for Positive Screen Follow-up for Sickle Cell Disease and Trait.

Faro EZ, Wang CJ, Oyeku SO.

Am J Prev Med. 2016 Jul;51(1 Suppl 1):S48-54. doi: 10.1016/j.amepre.2016.01.005.


Sickle Cell Disease: A Roadmap for Getting to Excellence Everywhere.

Homer CJ, Oyeku SO.

Am J Prev Med. 2016 Jul;51(1 Suppl 1):S3-4. doi: 10.1016/j.amepre.2015.10.018. No abstract available.


Improving Sickle Cell Transitions of Care Through Health Information Technology.

Frost JR, Cherry RK, Oyeku SO, Faro EZ, Crosby LE, Britto M, Tuchman LK, Horn IB, Homer CJ, Jain A.

Am J Prev Med. 2016 Jul;51(1 Suppl 1):S17-23. doi: 10.1016/j.amepre.2016.02.004.


Association between Hospital Volume and Within-Hospital Intensive Care Unit Transfer for Sickle Cell Disease in Children's Hospitals.

Raphael JL, Richardson T, Hall M, Oyeku SO, Bundy DG, Kalpatthi RV, Shah SS, Ellison AM.

J Pediatr. 2015 Dec;167(6):1306-13. doi: 10.1016/j.jpeds.2015.09.007. Epub 2015 Oct 23.


Mortality of New York children with sickle cell disease identified through newborn screening.

Wang Y, Liu G, Caggana M, Kennedy J, Zimmerman R, Oyeku SO, Werner EM, Grant AM, Green NS, Grosse SD.

Genet Med. 2015 Jun;17(6):452-9. doi: 10.1038/gim.2014.123. Epub 2014 Sep 25.


Pediatric hematology providers on referral for transplant evaluation for sickle cell disease: a regional perspective.

Mikles B, Bhatia M, Oyeku SO, Jin Z, Green NS.

J Pediatr Hematol Oncol. 2014 Oct;36(7):566-71. doi: 10.1097/MPH.0000000000000147.


Sickle cell disease pain management and the medical home.

Raphael JL, Oyeku SO.

Hematology Am Soc Hematol Educ Program. 2013;2013:433-8. doi: 10.1182/asheducation-2013.1.433. Review.


Hydroxyurea is associated with lower costs of care of young children with sickle cell anemia.

Wang WC, Oyeku SO, Luo Z, Boulet SL, Miller ST, Casella JF, Fish B, Thompson BW, Grosse SD; BABY HUG Investigators.

Pediatrics. 2013 Oct;132(4):677-83. doi: 10.1542/peds.2013-0333. Epub 2013 Sep 2.


Trends in blood transfusion among hospitalized children with sickle cell disease.

Raphael JL, Oyeku SO, Kowalkowski MA, Mueller BU, Ellison AM.

Pediatr Blood Cancer. 2013 Nov;60(11):1753-8. doi: 10.1002/pbc.24630. Epub 2013 Jun 18.


Hepatic Iron Quantification on 3 Tesla (3 T) Magnetic Resonance (MR): Technical Challenges and Solutions.

Anwar M, Wood J, Manwani D, Taragin B, Oyeku SO, Peng Q.

Radiol Res Pract. 2013;2013:628150. doi: 10.1155/2013/628150. Epub 2013 May 22. Erratum in: Radiol Res Pract. 2018 Jun 3;2018:8142478.


Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease.

Oyeku SO, Driscoll MC, Cohen HW, Trachtman R, Pashankar F, Mullen C, Giardina PJ, Velazco N, Racine AD, Green NS.

Pediatr Blood Cancer. 2013 Apr;60(4):653-8. doi: 10.1002/pbc.24381. Epub 2012 Nov 5.


Hemoglobinopathy Learning Collaborative: using quality improvement (QI) to achieve equity in health care quality, coordination, and outcomes for sickle cell disease.

Oyeku SO, Wang CJ, Scoville R, Vanderkruik R, Clermont E, McPherson ME, Adams WG, Homer CJ.

J Health Care Poor Underserved. 2012 Aug;23(3 Suppl):34-48. doi: 10.1353/hpu.2012.0127. Review.


Shorter hospitalization trends among children with sickle cell disease.

Raphael JL, Mueller BU, Kowalkowski MA, Oyeku SO.

Pediatr Blood Cancer. 2012 Oct;59(4):679-84. doi: 10.1002/pbc.24065. Epub 2012 Jan 4.


Administrative data sets and health services research on hemoglobinopathies: a review of the literature.

Grosse SD, Boulet SL, Amendah DD, Oyeku SO.

Am J Prev Med. 2010 Apr;38(4 Suppl):S557-67. doi: 10.1016/j.amepre.2009.12.015. Review.


Sickle cell disease: a question of equity and quality.

Smith LA, Oyeku SO, Homer C, Zuckerman B.

Pediatrics. 2006 May;117(5):1763-70.


Supplemental Content

Loading ...
Support Center